Shionogi & Co., Ltd. is a Japanese pharmaceutical company headquartered in Osaka, founded in 1878. The company specializes in the research, development, manufacturing, and distribution of medicines, focusing on areas such as oncology, infectious diseases, cardiovascular diseases, and neurology. Shionogi is known for its strong focus on innovation and quality in healthcare and is active in clinical research and the development of new therapeutic options. The company is also engaged in the global fight against pandemic diseases, such as COVID-19. Shionogi operates not only in Japan but also internationally, with a strong presence in Asia, Europe, and the United States.